Patents Assigned to Lumacyte, LLC
  • Patent number: 11041797
    Abstract: A microfluidic chip configuration wherein injection occurs in an upwards vertical direction, and fluid vessels are located below the chip in order to minimize particle settling before and at the analysis portion of the chip's channels. The input and fluid flow up through the bottom of the chip, in one aspect using a manifold, which avoids orthogonal re-orientation of fluid dynamics. The contents of the vial are located below the chip and pumped upwards and vertically directly into the first channel of the chip. A long channel extends from the bottom of the chip to near the top of the chip. Then the channel takes a short horizontal turn that nearly negates any influence of cell settling due to gravity and zero flow velocity at the walls. The fluid is pumped up to a horizontal analysis portion that is the highest channel/fluidic point in the chip and thus close to the top of the chip, which results in clearer imaging.
    Type: Grant
    Filed: December 23, 2017
    Date of Patent: June 22, 2021
    Assignee: LumaCyte, LLC
    Inventors: Sean Hart, Colin Hebert, Christopher Field, Shweta Krishnan
  • Patent number: 10871440
    Abstract: Provided are methods and devices for assessing biological particles for use in cell immunotherapy. By utilizing a microfluidic chip device together with optical force measurement and cell imaging, the methods enable comprehensive assessment and characterization of biological particles with regard to morphology, motility, binding affinities, and susceptibility to external forces, including but not limited to, chemical, biochemical, biological, physical and temperature influences. The methods enable the selection and production of biological particles, such as engineered T-cells, for use in immunotherapy and biomanufacturing.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: December 22, 2020
    Assignee: Lumacyte, LLC
    Inventors: Sean Hart, Colin Hebert